Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
A director at West Pharmaceutical Services Inc sold 1,800 shares at 330.780USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
The independent financial analyst theScreener just lowered the general evaluation of WEST PHARMACEUTICAL (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as moderately risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date January 14,...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
S&P 500 Testing Key Resistance As we have outlined in recent weeks, our base case continues to be for near-term consolidation while the market is in a “wait-and-see†phase as it relates to states re-opening. The S&P 500 is again testing key resistance at the 61.8% Fibonacci retracement level of 2934.49 and also the 2950-3000 level we previously identified. We continue to have concerns that lead us to believe the market is not yet out of the woods, however these concerns are counterbalanced ...
Encouraging Signs, But Not Out Of The Woods Positive news flow surrounding COVID-19 is encouraging on many fronts, and we welcome headlines such as peaking infections/deaths in Italy & Spain, certain European governments making plans to ease lockdowns, and that US death projections were likely overestimated. Despite encouraging news and the S&P 500 (SPX) hitting multi-week highs, market signals continue to suggest that this is a fairly standard bear market rally, making us believe the broad equ...
The Only Thing We Have To Fear Is Fear Itself This powerful quote from FDR can be applied to many facets of life. When it comes to the market, fear can lead investors to buy when it is time to sell, sell when it is time to buy, or freeze up altogether. Step one in conquering this issue starts with preparation and a gameplan. In our report from last Thursday (3/12) titled “Searching For A Bottom†we laid out our gameplan and what we need to see before having confidence that equity markets ar...
The Only Thing We Have To Fear Is Fear Itself This powerful quote from FDR can be applied to many facets of life. When it comes to the market, fear can lead investors to buy when it is time to sell, sell when it is time to buy, or freeze up altogether. Step one in conquering this issue starts with preparation and a gameplan. In our report from last Thursday (3/12) titled “Searching For A Bottom†we laid out our gameplan and what we need to see before having confidence that equity markets ar...
Key Points: • A number of Restaurant names are staging price and RS reversals or continue to have bullish formations. (ex. CHUY, JACK, CMG) • There are a few healthcare related names that continue to be bright spots and reflect leadership. (ex. CUTR, TFX, BSX, SYK, ADUS, CHE, COO, WST, TRHC, HUM, AMGN, PBH, MRK, and ZTS.) • REITs continue to show leadership characteristics' as many are hitting price and RS highs. (ex. OHI, SBRA, ESS, IRT, and MAA)
Key Points: • A number of Financial Sector names are at or near bullish price and RS inflections. (ex. WFC, ABCB, SNV, STL, NFBK, FII, and COF) • Many Healthcare Sector names are showing leadership characteristics. (ZBH, CUTR, UHS, HCA, CHE, AMED, WST, and NEOG) • Many IT service related names remain bullish. (ex. FISV, EBOV, GPN, TSS, and EXLS)
Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR
Founded in 1923, West Pharmaceutical Services has spent the past 95 years building an impressive business that we think has been effective in constructing a wide economic moat. The success of the franchise has rested upon management's decision to focus on reinvesting behind the firm's core competency, namely, the manufacture of rubber-based components used in the packaging, storage, and administration of injectable therapeutics. Instead of utilizing the firm's balance sheet to acquire assets and...
Wide-moat West Pharmaceutical Services reported a strong start to its year with organic revenue expanding 11%, led by its high-value product portfolio that expanded nearly 20% on a reported basis, by our math. We'll probably bump up our $100 fair value estimate by a mid-single-digit percentage as we tweak our model to account for this better-than-expected growth. However, with the stock currently trading at over 40 times our 2019 adjusted earnings estimate, we have a hard time strongly recommend...
Wide-moat West Pharmaceutical Services reported a strong start to its year with organic revenue expanding 11%, led by its high-value product portfolio that expanded nearly 20% on a reported basis, by our math. We'll probably bump up our $100 fair value estimate by a mid-single-digit percentage as we tweak our model to account for this better-than-expected growth. However, with the stock currently trading at over 40 times our 2019 adjusted earnings estimate, we have a hard time strongly recommend...
Wide-moat West Pharmaceutical Services reported a strong start to its year with organic revenue expanding 11%, led by its high-value product portfolio that expanded nearly 20% on a reported basis, by our math. We'll probably bump up our $100 fair value estimate by a mid-single-digit percentage as we tweak our model to account for this better-than-expected growth. However, with the stock currently trading at over 40 times our 2019 adjusted earnings estimate, we have a hard time strongly recommend...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Founded in 1923, West Pharmaceutical Services has spent the past 95 years building an impressive business that we think has been effective in constructing a wide economic moat. The success of the franchise has rested upon management's decision to focus on reinvesting behind the firm's core competency, namely, the manufacture of rubber-based components used in the packaging, storage, and administration of injectable therapeutics. Instead of utilizing the firm's balance sheet to acquire assets and...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.